Navigation Links
Amedica® Closes $30 Million Financing
Date:9/7/2010

SALT LAKE CITY, Sept. 7 /PRNewswire/ -- Amedica Corporation, a developer of a broad range of innovative, unique spine and total joint implants, announced that it has completed a $30 million financing.  The financing consists of $15 million in private equity and a debt facility of $15 million.  Zions First National Bank provided the debt facility, and Creation Capital of New York and Austin, Texas, acted as the placement agent for the private equity piece.  Creation Capital is an established banking concern that specializes in high-growth emerging health care technologies.

The proceeds from this financing will be used for expansion, mergers and acquisitions, sales and marketing support.  Ben Shappley, Chief Executive Officer, President and Director of Amedica stated, "We are pleased to complete this transaction that will enable and further sustain our substantial growth.  We are currently experiencing a challenging period in the capital markets and the overall struggling economy.  Our success in completing this and other recent strategic financings clearly speaks to the importance of our platform technologies, our vast intellectual property estate and investor confidence in the strength of our organization."

Amedica has completed transactions in excess of $100 million in the recent past to support and grow the company's technology assets and value.  Amedica has shown solid growth at a CAGR of 24% increase over the last six quarters in its spinal implant business.  

About Amedica:

Amedica Corporation is ISO 13485 certified and its products are FDA cleared and CE approved.  Amedica Corporation is an emerging orthopaedic implant company focused on using its silicon nitride ceramic and other technologies to develop and commercialize a broad range of innovative, unique spine and total joint implants for the growing orthopaedic device market.  It has brought to market various spinal implant products, while products under development include reconstructive hip and knee implants that represent a new standard of care in total joint implants based on superior performance, safety and efficacy.


'/>"/>
SOURCE Amedica Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Amedica® Receives Patent for Knee Prosthesis With Monoblock Silicon Nitride Ceramic Tibial Component
2. Amedica® Receives Patent for Hip Implant Using Monoblock Ceramic Technology
3. Warner Chilcott Completes Amendment to Existing Senior Secured Credit Facilities and Closes Senior Notes Offering; Company Declares Special Cash Dividend of $8.50 Per Share and Updates Full-Year 2010 Financial Guidance
4. International Research Team Closes In On Cause of Common Form of Muscular Dystrophy
5. SI-BONE, Inc. Closes $11.0 Million Financing Led by Skyline Ventures
6. Sangon & Bio Basic Inc. Closes $10 Million Round of Investment by Qiming Ventures
7. RoundTable Healthcare Partners Closes Two Funds
8. iPierian Closes $22 Million Series B Financing Led By Google Ventures
9. Micromet Closes $80.5 Million Public Offering of Common Stock
10. Cheetah Medical Closes $20 Million Series B Financing
11. Castle Access Closes Equity Capital Financing to Provide for Accelerated Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2017)... , Sept. 6, 2017 NeuroRx, a clinical stage ... Ideation and Behavior (ASIB), has been granted Fast Track status ... therapy of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + ... pivotal trial of this sequential therapy targeting patients who are ... ...
(Date:9/5/2017)...  Xyntek Inc. has announced another milestone in their continued growth and success ... the growing demands of customer engagements regionally.  ... new Midwest office is located at 318 West Adams Street, Suite 1528, Chicago, ... Xyntek's recently opened ... ...
(Date:9/5/2017)... , Sept. 5, 2017 Oramed Pharmaceuticals Inc. ... ), a clinical-stage pharmaceutical company focused on the development ... has successfully concluded its meeting with the U.S. Food ... oral insulin formulation. ... the regulatory pathway for submission of ORMD-0801, would be ...
Breaking Medicine Technology:
(Date:9/25/2017)... ... September 25, 2017 , ... PITTSBURGH...An inventor, from Richmond Hill, ... charts in hospitals and medical facilities, so he invented the COMPLETE PATIENT CHART. , ... charts. In doing so, it offers an improved alternative to paper charts and clipboards. ...
(Date:9/25/2017)... Pa. (PRWEB) , ... September ... ... provider of specialized science and technology-enabled services supporting clinical research, today announces ... topics addressing key aspects of the drug development lifecycle at upcoming industry ...
(Date:9/25/2017)... , ... September 25, 2017 , ... Earlypicker is expanding ... a one-stop shop for the hottest Korean cosmetics and fashion trends sweeping the nation. ... company that’s already well-known for the great offerings that allow Koreans everywhere to look ...
(Date:9/25/2017)... ... September 25, 2017 , ... “The Majestic Unicorn”: a poignant book that ... Unicorn” is the creation of published author, Dayna Chantel, an artist and a writer. ... wide to march aboard the cypress ark-vessel. Male and female, no matter what species, ...
(Date:9/25/2017)... , ... September 25, 2017 , ... Emerald Ash Borers kill Ash trees ... be seen throughout the Philadelphia region. A video by Rob Nagy, ISA Certified Arborist ... Ash trees. While several are dead or showing signs of decline from Emerald Ash ...
Breaking Medicine News(10 mins):